Target Price | CHF509.93 |
Price | CHF547.60 |
Deviation | 6.88% |
Number of Estimates | 18 |
18 Analysts have issued a price target Zurich Insurance Group 2025 . The average Zurich Insurance Group target price is CHF509.93. This is 6.88% lower than the current stock price. The highest price target is CHF599.11 9.41% , the lowest is CHF414.86 24.24% . | |
A rating was issued by 20 analysts: 3 Analysts recommend Zurich Insurance Group to buy, 14 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Zurich Insurance Group stock has an average upside potential 2025 of 6.88% . Most analysts recommend the Zurich Insurance Group stock at Hold. |
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Billion CHF | 70.28 | 51.25 |
76.41% | 27.08% | |
Net Margin | 5.52% | 9.88% |
48.48% | 79.14% |
7 Analysts have issued a sales forecast Zurich Insurance Group 2024 . The average Zurich Insurance Group sales estimate is CHF51.3b . This is 21.65% lower than the revenue of the last 12 months(TTM). The highest sales forecast is CHF61.7b 5.73% , the lowest is CHF39.7b 39.27% .
This results in the following potential growth metrics:
2023 | CHF70.3b | 76.41% |
---|---|---|
2024 | CHF51.3b | 27.08% |
2025 | CHF54.0b | 5.37% |
2026 | CHF56.1b | 3.81% |
2027 | CHF57.5b | 2.58% |
2028 | CHF59.7b | 3.85% |
15 Zurich Insurance Group Analysts have issued a net profit forecast 2024. The average Zurich Insurance Group net profit estimate is CHF5.1b . This is 16.74% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF5.5b 26.73% , the lowest is CHF4.5b 4.32% .
This results in the following potential growth metrics and future Net Margins:
2023 | CHF3.9b | 9.12% |
---|---|---|
2024 | CHF5.1b | 30.57% |
2025 | CHF5.5b | 8.79% |
2026 | CHF5.9b | 7.03% |
2027 | CHF6.3b | 7.36% |
2028 | CHF5.9b | 6.17% |
2023 | 5.52% | 48.48% |
---|---|---|
2024 | 9.88% | 79.14% |
2025 | 10.20% | 3.24% |
2026 | 10.51% | 3.04% |
2027 | 11.00% | 4.66% |
2028 | 9.94% | 9.64% |
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share CHF | 26.92 | 35.15 |
9.12% | 30.57% | |
P/E | 15.11 | |
EV/Sales | 1.63 |
15 Analysts have issued a Zurich Insurance Group forecast for earnings per share. The average Zurich Insurance Group <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is CHF35.15 . This is 16.74% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is CHF38.16 26.74% , the lowest is CHF31.41 4.32% .
This results in the following potential growth metrics and future valuations:
2023 | CHF26.92 | 9.12% |
---|---|---|
2024 | CHF35.15 | 30.57% |
2025 | CHF38.24 | 8.79% |
2026 | CHF40.93 | 7.03% |
2027 | CHF43.94 | 7.35% |
2028 | CHF41.23 | 6.17% |
Current | 17.63 | 25.75% |
---|---|---|
2024 | 15.11 | 14.29% |
2025 | 13.89 | 8.07% |
2026 | 12.97 | 6.62% |
2027 | 12.08 | 6.86% |
2028 | 12.88 | 6.62% |
Based on analysts' sales estimates for 2024, the Zurich Insurance Group stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 1.63 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 1.47 .
This results in the following potential growth metrics and future valuations:
Current | 1.28 | 0.00% |
---|---|---|
2024 | 1.63 | 27.55% |
2025 | 1.55 | 5.10% |
2026 | 1.49 | 3.68% |
2027 | 1.46 | 2.51% |
2028 | 1.40 | 3.71% |
Current | 1.15 | 3.41% |
---|---|---|
2024 | 1.47 | 27.63% |
2025 | 1.39 | 5.10% |
2026 | 1.34 | 3.67% |
2027 | 1.31 | 2.52% |
2028 | 1.26 | 3.71% |
Zurich Insurance Group...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.